The field of synthetic biology continues to evolve by leaps and bounds, which was once again demonstrated today by experts from the Higher Polytechnic School of Zurich in Switzerland – a team of scientists was able to modify the work of the popular CRISPR gene modifier to integrate dual-core processors into human cells. This sounds rather strange and even impossible, but in reality everything turns out to be real and very logical, since the human body itself is in some way a computer with certain algorithmic mechanisms of momentum and result.
Keeping this comparison in mind, specialists from Switzerland were able to modify the sequential gene editing technique CRISPR in order to change the work of the most important enzyme Cas9 used in gene therapy and sections. As part of this experiment, scientists changed the functions of the enzyme so that it worked as a digital command post, collecting one or two impulses and launching, depending on these impulses, a certain result of metabolism and internal cellular processes.
Moreover, the enzyme itself, in its dual-core processor status, was built directly into the cells – which allowed scientists not only to significantly reduce its size, but also to increase the “digital” functionality, adding links to some additional genes and gene chains. This led to the next stage in the development of synthetic biology, which in the future, potentially, will be able to provide and offer much more complex processes and operations of this kind.
It is worth noting that so far development is experimental and, of course, will continually improve and refine over time, which is also associated with the need to improve the internal functionality of such a modified enzyme. In addition, if specialists can present a modified version of the development, then it will soon have every chance of becoming part of the current CRISPR system, which can increase its functionality and capabilities.